Terlipressin - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Terlipressin: Serious or fatal respiratory failure and sepsis/septic shock in patients with type 1 hepatorenal syndrome (type 1 HRS)

Key facts

• Active substance:
  Terlipressin
• Therapeutic area (MeSH):
  Vasopressins
• Procedure number:
  EMEA/H/A-31/1514
• Regulatory outcome:
  Variation
• DHPC type:
  Referral - Article 31
• Human ATC codes:
  H01BA04
• Dissemination date:
  01/12/2022
• Related medicines:
  Glypressin, Terlipressin Acetate and Variquel